Impact of menopause on the brain

Alzheimer Disease and Associated Disorders

Volumn 17, Issue SUPPL. 2, 2003, Pages

  Wise, Phyllis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL PROTECTION; CELL REGENERATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GENE FUNCTION; LIFE EXPECTANCY; MENOPAUSE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0037633247     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200304002-00005     Document Type: Conference Paper

References (19)

1. Asthana S, Baker LD, Craft S, et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 2001;57:605-12.
2. Dubal DB, Wise PM. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001;142:43-8,
3. Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000;54:295-301.
4. Henderson VW, Watt L, Buckwalter JG. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1997;21:421-30.
5. Huang Y, Ray S, Reed JC, et al. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 1997;42:73-81.
6. Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab 1999;84:606-10.
7. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
8. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 1995;9:659-69.
9. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 2000;283:1007-15.
10. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog Cardiovasc Dis 1995;38:223-42.
11. Sherwin BB. Estrogenic effects on memory in women. Ann NY Acad Sci 1994;743:213-30.
12. Sherwin BB. Estrogen effects on cognition in menopausal women. Neurology 1997;48(5 suppl 7):S21-6.
13. Shughrue PJ, Komm B, Merchenthaler I. The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids 1996;61:678-81.
14. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-32.
15. Toran-Allerand CD. Organotypic culture of the developing cerebral cortex and hypothalamus: relevance to sexual differentiation. Psychoneuroendocrinology 1991;16:7-24.
16. West SG, Stoney CM, Hughes JW, Matacin M, Emmons KM. Oral contraceptive use is associated with increased cardiovascular reactivity in nonsmokers. Ann Behav Med 2001;23:149-57.
17. Wilson ME, Dubal DB, Wise PM. Estradiol protects injury-induced cell death in cortical explant cultures: a role for estrogen receptors. Brain Research 2000;873:235-42.
18. Wise PM, Dubal DB, Wilson ME, Ran SW. Estradiol is a neuroprotective factor in in vivo and in vitro models of brain injury. J Neurocytol 2000;29:401-10.
19. Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M, Rosewell KL. Estradiol is a protective factor in the adult and aging brain. undrstanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev 2001;37:313-9.